Alydia Health

Alydia Health is a medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) and abnormal postpartum uterine bleeding.

Alydia is working toward a solution for postpartum bleeding and hemorrhage (PPH), the number one cause of maternal death.

Alydia Health was founded in 2010 by Jessie Becker and Nathan Bair. The company is headquartered in Menlo Park, California.

 

Alydia has developed Jada System, a unique device intended to rapidly stop excessive bleeding by encouraging the normal contractions that should happen after childbirth. Jada is designed to use gentle suction to collapse an exhausted uterus quickly, and encourage it to contract fully on its own.

 

Alydia Health is backed by AXA Investment Managers, Global Health Investment Fund and Avestria Ventures. The company raised $13.9M in Series C round on Jul 30, 2020. This brings Alydia's total funding to $24.2M to date.

 

 

  • Year founded: 2010
  • Funding Info: $24.2M over 2 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Menlo Park
  • State: California
  • Country: United States
Related businesses